Ionizing radiation, sunlight, and chemicals that interact with DNA are generally cytotoxic, mutagenic, and oncogenic. Cell killing, is an essential end effect in the therapy of cancer. The lethal effects of radiation are radiation are also important in mutagenesis and neoplastic transformation because cell viability is required for these endpoints to be expressed. In people, radiation has been established as a mutagenic and oncogenic agent; a number of chemicals, including photosensitizers of cells like the polycyclic aromatic hydrocarbons (PAH's), are recognized to have similar properties. For these reasons, a study of the biological effects of radiation and genotoxic chemicals is relevant both to issues of public health and the treatment of cancer. Each part of this proposal is directed at basic radiobiological and molecular processes in mammalian cells. Still, an underlying them is the roles of repair and cell kinetics in the endpoints above. For example, in mutagenesis, we seek to understand why the yield of mutations decreases with dose rate; if this decrease is accompanied by qualitative shifts in the genotypes that are produced; and what role repair competence plays in such shifts. In connection with chemical agents that may be present in the environment along with radiation, we have determined that one PAH can reduce the effectiveness of another. The implications of this observation will be followed up first because repair-stimulated PAH action is important in its own right, and second because a determination of how radiation and PAH's in the environment interact requires that the action of each should be understood. Lastly, the observation of enhanced sensitivity of G2-/M-phase cells to killing, mutation, and transformation will be vigorously pursued because of the role of mitosis in cancer biology, and because this cell-cycle window of sensitivity leads to important predictions of the effects of low, protracted doses of radiation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Unknown (R35)
Project #
2R35CA047497-07
Application #
2092591
Study Section
Special Emphasis Panel (SRC (88))
Project Start
1988-05-01
Project End
1999-03-31
Budget Start
1994-06-01
Budget End
1995-03-31
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Colorado State University-Fort Collins
Department
Radiation-Diagnostic/Oncology
Type
Schools of Veterinary Medicine
DUNS #
112617480
City
Fort Collins
State
CO
Country
United States
Zip Code
80523
Chernikova, S B; Lindquist, K L; Elkind, M M (2001) Cell cycle-dependent effects of wortmannin on radiation survival and mutation. Radiat Res 155:826-31
Lang, S; Marchesani, M; Servomaa, K et al. (1999) p53 gene mutations in neoplastic transformation of C3H 10T1/2 and severe combined immunodeficiency fibroblasts. Mutat Res 434:61-5
Chernikova, S B; Wells, R L; Elkind, M M (1999) Wortmannin sensitizes mammalian cells to radiation by inhibiting the DNA-dependent protein kinase-mediated rejoining of double-strand breaks. Radiat Res 151:159-66
Lun, M; Wells, R L; Lang, S et al. (1999) The neoplastic transformation of SCID cells by radiation. Radiat Res 152:180-9
Elkind, M M (1999) Does repair of radiation damage play a role in breast cancer? Radiat Res 152:567
Wells, R L; Hu, Q; Xing, Y et al. (1998) Phase transitions in the growth of C3H 10T1/2 cells. Radiat Res 149:508-16
Elkind, M M (1997) Cell-cycle sensitivity, recovery from radiation damage and a new paradigm for risk assessment. Int J Radiat Biol 71:657-65
Xing, Y; Wells, R L; Elkind, M M (1996) Nonradioisotopic PCR heteroduplex analysis: a rapid, reliable method of detecting minor gene mutations. Biotechniques 21:186-7
Elkind, M M (1996) Enhanced risks of cancer from protracted exposures to X- or gamma-rays: a radiobiological model of radiation-induced breast cancer. Br J Cancer 73:133-8
Shen, Z; Wells, R L; Elkind, M M (1994) Enhanced cytochrome P450 (Cyp1b1) expression, aryl hydrocarbon hydroxylase activity, cytotoxicity, and transformation of C3H 10T1/2 cells by dimethylbenz(a)anthracene in conditioned medium. Cancer Res 54:4052-6

Showing the most recent 10 out of 32 publications